Abstract. Somatic cell nuclear transfer (SCNT) can provide a unique alternative for the preservation of valuable individuals, breeds and species. However, with the exception of a handful of domestic animal species, successful production of healthy cloned offspring has been challenging. Progress in species that have little commercial or research interest, including many companion animal, non-domestic and endangered species (CANDES), has lagged behind. In this review, we discuss the current and future status of SCNT in CANDES and the problems that must be overcome to improve preand post-implantation embryo survival in order for this technology to be considered a viable tool for assisted reproduction in these species.
Introduction
SCNT, the transplantation of a nucleus from a desired donor individual into the enucleated oocyte of another individual, provides a unique alternative for the preservation of genetic material. First, this technique allows you to preserve the genetics from individuals: (1) who have died prematurely or unexpectedly; (2) in their prime reproductive years experiencing reproductive dysfunction; (3) in their post-reproductive years who have failed or lacked the opportunity to breed; (4) who have not been chosen for breeding; and (5) who have been castrated. In most of these cases, the collection of viable gametes will not be realised, which precludes reproduction by conventional methods. Second, the collection and banking of somatic cells is less invasive and easier to implement, particularly in field conditions, than the specialised procedures required for the collection and cryopreservation of gametes and embryos, making this an attractive option for the transfer of genetic material from free-ranging to captive populations. Most importantly, this technique allows preservation and screening of the entire genome from an individual, thereby avoiding dilution of valuable alleles. For these reasons, SCNT has the potential to become a powerful instrument for the genetic management of valuable individuals, breeds and species.
Over the past 10 years, SCNT has been extensively applied to domestic (cattle: Wells et al. 1999; sheep: Wilmut et al. 1997; pig: Polejaeva et al. 2000; goat: Baguisi et al. 1999 ) and laboratory (mouse: Wakayama et al. 1998; rat: Hayes et al. 2001; rhesus monkey: Wolf et al. 1999; ferret: Li et al. 2006b ) animal species, mainly to propagate identical individuals. This is a critical component in the production of: (1) individuals carrying valuable and/or desirable genetic traits; (2) animal models of disease; and (3) samples for the investigation of the fundamental aspects of pre-and post-implantation embryo development and fetal-maternal interactions. Recently, there has been increasing interest in including SCNT into the array of assisted reproductive technologies available for CANDES.
Currently, the CANDES committee's position on cloning recognises that some species may benefit from SCNT technology or may be appropriate models for research that has a broader application (http://www.omahazoo.com/iets/CloningStatement. PDF, verified May 2007) . Thus, the committee supports research and development of the technology, including the collection and storage of genetic material, but cautions that cloning research should not be carried out at the expense of research that is deemed more beneficial or applicable to CANDES (e.g. basic reproductive physiology, artificial insemination, in vitro fertilisation, embryo transfer).
SCNT in companion animals
SCNT has re-emerged as a commercial opportunity in an application unrelated to the food and pharmaceutical industries. The role of companion animals in the emotional well being of their owners has formed a niche for SCNT as a method for the recreation of beloved pets. This has led to the appearance of banking facilities for the purpose of obtaining and storing cells from living or recently deceased animals. Interestingly, consumer demand for genome banking has surpassed the availability of reproducible and successful SCNT techniques in these species.
Of companion animal species, primarily the cat, dog and horse, the greatest SCNT success has been achieved with the domestic cat. Following the birth of the first cloned kitten, reported by Shin et al. in 2002 , other research and commercial groups have subsequently produced live clones (Ball 2005; Yin et al. 2005) . Access to a considerable number of ovaries from spays at local veterinary clinics and successful protocols for the in vitro production and transfer of cat embryos has allowed progress to be made with SCNT. However, unlike domestic animal species, embryo development remains low, with only 0-10.5% of reconstructed embryos reaching the blastocyst stage (Skrzyszowska et al. 2002; Gomez et al. 2003; Kitiyanant et al. 2003; Wen et al. 2003; Yin et al. 2005 Yin et al. , 2006b ). Furthermore, poor post-implantation survival of the clones is similar to that observed in all species (pregnancy rate per embryo: 0.6-2.3%; live birth rate per embryo: 0.3-1.2%; Shin et al. 2002a; Yin et al. 2005) .
Despite extensive efforts by a few laboratories to optimise SCNT techniques for the domestic dog, success has been elusive. Difficulties with maturation of canine oocytes in vitro have inhibited the establishment of a viable SCNT technique owing to the lack of large numbers of good-quality recipient cytoplasts necessary to examine such parameters as fusion and activation methods. In addition, in vitro culture of dog embryos has not progressed largely because of the complexities encountered with in vitro oocyte maturation. Although the development of dog SCNT embryos in vitro has been documented, blastocysts were observed only when bovine oocytes were used as recipients for dog donor cells (Westhusin et al. 2001; Murakami et al. 2005) . As with the domestic cat, poor embryo development corresponded to poor post-implantation survival (pregnancy rate per embryo: 0-0.3%; live birth rate per embryo: 0-0.2%; Westhusin et al. 2001; Lee et al. 2005) . The first report of live cloned dogs was in 2005, when Lee et al. announced the birth of two male Afghan hounds using in-vivo-matured oocytes. The same research group has recently used in-vivo-matured oocytes to successfully produce female puppies (Jang et al. 2007) .
Advancement of SCNT in the horse has been plagued by two factors, insufficient numbers of oocytes related to minimal access to ovaries and difficulties involved with in vitro embryo production. Even so, significant progress has been made in achieving blastocyst development of reconstructed embryos (1.3-16%; Galli et al. 2003; Hinrichs 2005; Lagutina et al. 2005; Hinrichs et al. 2006) . Furthermore, post-implantation survival rates were high with pregnancy rates per embryo ranging from 2.3 to 37.5%. The birth of the first live cloned foal in 2003 by Galli et al. has been followed by numerous live births (live birth rate per embryo: 1.9-25%; Hinrichs 2005; Lagutina et al. 2005; Hinrichs et al. 2006) .
SCNT in non-domestic and endangered species
Interest in SCNT as a method for embryo production in nondomestic and endangered species stems from the necessity for implementing assisted reproductive technologies as alternative strategies for the genetic management of wild and captive populations. Space availability, small numbers of individuals, behaviour, nutrition, health and welfare and reproductive failure have a major effect on traditional captive breeding programs (Lasley et al. 1994) . SCNT can provide unique opportunities for overcoming these limitations and enabling the distribution of genetic material, thereby promoting the maintenance and/or improvement of the genetic make-up of captive-bred species.
Establishment and effective management of cell banks can be used in conjunction with assisted reproductive technologies to provide animal managers with yet another method to safeguard populations against the sudden loss of genetic diversity and possible extinction.
Current success rates for SCNT require that large numbers of reconstructed embryos be produced and transferred to ensure the birth of live offspring. Since oocytes from exotic animals are rare and difficult to obtain, the quantities required for producing nuclear transfer embryos would not be readily available. To overcome this major drawback, numerous attempts have been made using oocytes from related domestic species as recipients for the exotic donor nuclei, a technique known as interspecies/intergeneric SCNT. It has been repeatedly shown that recipient cytoplasm of domestic species can sufficiently reprogram the exotic donor nucleus to produce preimplantation SCNT embryos and, in some cases, establish pregnancies (Table 1) . However, despite numerous attempts in a wide variety of species, the number of live births of cloned offspring is minimal. As with companion animal species, the proportion of reconstructed embryos that result in live offspring following transfer is rather low (Table 1) . In most cases, the effort was documented but never repeated, limiting the acquisition of knowledge in these species.
Domestic cattle cytoplasm has shown great versatility in its ability to support the nuclei of various species by allowing development of reconstructed embryos beyond preimplantation stages, suggesting that it is capable of reprogramming, at least partially, diverse donor nuclei through maternal-embryonic transition (Table 1) . Availability of ovaries from local abattoirs and a great understanding of bovine embryo development in vitro and in vivo have played a major role in the success of SCNT in nondomestic bovids. SCNT embryos develop to the blastocyst stage at reasonable rates ranging from 12 to 13% in the gaur (Lanza et al. 2000; Mastromonaco et al. 2007 ) to 34% in the buffalo (Saikhun et al. 2002) ; whereas llama SCNT embryos were not capable of developing past the early cleavage stages (Sansinena et al. 2003) . Both wild cattle species in which transfer of SCNT embryos was attempted resulted in a live birth (gaur: Lanza et al. 2000; banteng: Sansinena et al. 2005) ; however, the gaur calf died and one of two banteng calves had to be euthanised within days of birth.
Unlike in bovine species, SCNT success in domestic sheep has not been highly exploited. Interspecies SCNT has only been attempted with a few non-domestic sheep species (Table 1) . With the exception of the mouflon, in which 30.4% of the reconstructed embryos developed to the blastocyst stage (Loi et al. 2001) , poor embryo development was followed by low postimplantation survival (pregnancy rate per embryo: 3.6-8.7%; live birth rate per embryo: 0-4.3%; White et al. 1999; Loi et al. 2001) . Thus, only one live birth, a mouflon, has been reported (Loi et al. 2001) .
As with the domestic cat, SCNT in non-domestic cats has had numerous successes (Table 1) . Blastocyst development similar to, and in some cases higher than, domestic cat SCNT have been reported (0-24.2%; Gomez et al. 2003 Gomez et al. , 2006a Thongphakdee et al. 2006; Yin et al. 2006a) . Interestingly, interspecies SCNT using domestic cat oocytes as recipients for African wild cat cells resulted in greater blastocyst rates (24.2%) than domestic cat cells (3.3%; Gomez et al. 2003) . In the marbled cat, fusion with cat oocytes did not produce any blastocysts whereas fusion with rabbit oocytes did result in blastocyst development (11.5%; Thongphakdee et al. 2006) . Once again, low pregnancy (1.4-1.6%, per embryo) and live birth (0-0.5%, per embryo) rates were observed (Gomez et al. 2004; Yin et al. 2006a) . Several factors influence SCNT outcome in non-domestic species. First, the degree of homogeneity between the donor nucleus and recipient cytoplasm may affect embryo developmental potential and will be discussed in further detail below. Second, embryos are usually transferred into recipients from a related domestic species. Thus, the poor pregnancy outcomes could be a consequence of the SCNT procedure, the interspecific embryo transfer or a combination of both factors. Previous studies on the interspecific transfers of gaur embryos into domestic cattle recipients indicate that there are several pregnancy-associated problems, including abnormal placental development, fetal malnourishment and hypoxia (Hradecky et al. 1988; Hammer et al. 2001) , which are similar to the outcomes of SCNT pregnancies.
Complexity of SCNT success
The production of viable offspring from SCNT embryos is dependent on the ability of the differentiated donor nucleus to be reprogrammed successfully to initiate proper embryonic and fetal gene expression. This process is affected by numerous factors, including: suitability of nuclear donor cells and recipient cytoplasm; compatibility between the karyoplast and cytoplast; technical efficiency (enucleation, fusion, oocyte activation); and optimal culture conditions (Campbell 1999; Smith et al. 2000a ). Individual and species-specific differences in chromosome number and genome-related events, including maternal-embryonic transition, greatly influence the outcome. Although SCNT embryos often reach the blastocyst stage, the low percentage of transferred embryos that undergo fetal development to term-gestation suggests that SCNT embryos are developmentally compromised. To improve the percentage of live offspring, the factors listed above must be investigated for each candidate species for SCNT.
The donor individual
In many instances, donor individuals are selected for SCNT because of their inability to produce living offspring or their minimal genetic contribution to the population. Thus, the possibility exists that these animals have an underlying (potentially deleterious) condition, which precludes the production of progeny, given adequate opportunities to breed. The reasons for reproductive failure or inefficiency of a potential SCNT donor must be taken into consideration, as many causes of reproductive dysfunction originate from chromosomal or genetic defects, which will be perpetuated in cloned offspring.
In a recent study in our laboratory, a female gaur (Bos gaurus) was selected as a nuclear donor because she was only two generations removed from the founders and had poor reproductive success. Cytogenetic analysis before SCNT revealed that she was a carrier of a Robertsonian translocation involving chromosomes 1 and 29, thereby reducing her diploid chromosome number by 1 from the normal 2n = 58 to 2n = 57 (Mastromonaco et al. 2004a ). This same translocation has been associated with decreased fertility in numerous domestic cattle breeds (Gustavsson 1969; Dryendahl and Gustavsson 1979; Rangel-Figueiredo and Iannuzzi 1991) owing to the production of chromosomally unbalanced gametes that, subsequent to fertilisation, result in early embryonic death (Popescu 1990) .
Studies in other non-domestic species have demonstrated the occurrence of Robertsonian translocations in both captive and wild animals. Analysis of individuals in wild populations of white rhinoceros (Ceratotherium simum) led to the identification of a translocation in a male and his two female offspring (Houck et al. 1994) . Arabian oryx (Oryx leucoryx), critically endangered after having been declared extinct in the wild, are carriers of a 17;19 translocation, with 8 out of 62 animals being affected (Cribiu et al. 1990) . Similarly, carriers of a translocation involving chromosomes 2 and 15 were found in captive-born scimitar-horned oryx (Oryx dammah) (Kumamoto et al. 1999) . Chromosomal analysis of gazelles (Gazella subgutturosa marica) from three captive populations revealed the presence of chromosomal polymorphisms due to translocations (Vassart et al. 1993) .
Careful cytogenetic screening of donors before their use in assisted reproduction techniques has become an important prerequisite for domestic animal breeding strategies. Proper management of breeding individuals is necessary to prevent the dissemination of chromosome abnormalities. This is particularly important when working with non-domestic species since, in most cases, little is known about the chromosomal make-up of captive herds. As with many companion animal breeds, captive-bred non-domestic species are highly inbred since they are descendents of a small group of founder individuals, thereby increasing the likelihood of chromosomal aberrations in the population. Studies in vitro have shown that chromosomal abnormalities in preimplantation embryos are associated with poor embryo quality and embryonic/fetal wastage (Kawarsky et al. 1996; Viuff et al. 2000; Booth et al. 2003) . Chromosome anomalies in a nuclear donor enhance the possibility of decreased developmental outcome and emphasise the need for genetic screening before selection for SCNT.
The donor cell
One of the most important requirements for SCNT success is the production of viable and normal donor cell lines. Animal cloning requires that somatic cells be collected from a donor individual, cultured in vitro for several passages and then induced to enter quiescence by serum starvation, confluency or cell cycle inhibitors. Proper preparation of the donor cell is necessary to allow for sufficient reprogramming of the nucleus in the reconstructed embryo so that normal gene expression events can occur, a critical factor for post-implantation survival.
Cells grown in vitro differ from their in vivo counterparts in that they must survive the trauma of being separated and grow as single cells in monolayers rather than multi-dimensional. During this event, cells experience major changes in their physical environment, their interaction with one another and the nature of their growth parameters (Rubin 1997) . Environmental and genetic factors can seriously affect the in vitro growth characteristics and replicative lifespan of cultured cells. Age of the donor, species, tissue type, culture conditions (oxygen tension, medium) and seeding density play a role in cell growth and longevity (Campisi 1997; Balin et al. 2002) .
Methods used for sample collection and culture establishment influence viability of cells grown in vitro. Cells obtained from tissue collected post-mortem and kept at 0 • C for 24 h followed by storage at −30 • C for 2 years did not replicate in culture, whereas tissue collected and kept in phosphate-buffered saline at 4 • C for up to 60 h or frozen in liquid nitrogen in cryoprotectant was capable of achieving confluence in several days (Uoc et al. 2002) . When these cells were used for SCNT, only the latter produced blastocysts (26-44%; Uoc et al. 2002) . In a similar study, bovine donor cells were prepared from fresh, cold-stored at 4 • C or dead cells and the corresponding blastocyst rates following SCNT were 18%, 10% and 0% respectively (Li et al. 2002) . Adams et al. (2004) subsequently demonstrated the production of blastocysts and the birth of a live cloned calf using kidney cells that had been collected from a carcass cooled for 48 h. A recent study in our laboratory demonstrated that tissue sample collection and cell dissociation techniques influence in vitro growth characteristics and lifespan, morphology, chromosome content and telomere dynamics . Biopsies obtained by darts or manual punches resulted in lower quality cell lines compared with larger samples collected immediately post-mortem from skin or ear, particularly when prepared by explanting instead of enzymatic digestion. Cells obtained by the former methods exhibited decreased lifespan (<30 versus >50 population doublings respectively), morphological changes characteristic of senescence ( Fig. 1 ) and increased percentages of chromosomal abnormalities (up to 58% versus <20% respectively; Mastromonaco et al. 2006) .
Prolonged culture affects viability and normality of cells, which is manifested in numerous ways, including genomic instability and telomere shortening (Benn 1976; Allsopp et al. 1992; Hamilton et al. 2001; Balin et al. 2002) , both of which have been correlated with poor developmental outcome exhibited as delayed development, decreased total cell numbers and increased incidence of fragmentation (Viuff et al. 2000; Liu et al. 2002; Booth et al. 2003; Keefe et al. 2005) . Slimane Bureau et al. (2003) demonstrated that the incidence of chromosome abnormalities in SCNT embryos was correlated with that present in the donor cell line used. Bovine donor cell lines with a high percentage of abnormal cells produced embryos with high rates of chromosomal abnormalities compared with donor cell lines with a low percentage of abnormal cells (Slimane Bureau et al. 2003) . Similar results were obtained by Gomez et al. (2006b) using African wild cat fibroblasts, which were 98% abnormal after only nine passages in vitro. Lack of embryo development beyond the 16-32 cell stage in vitro was observed following Argali sheep SCNT (Loi et al. 2001) . Analysis of the chromosome content of the donor cells found that, although the early passage cultures were chromosomally normal, cells from passages 7-10 used as donors for SCNT had increased levels of abnormalities (Loi et al. 2001) . Our results corroborate that a relationship exists between the status of the donor cell and the quality of the embryos produced by SCNT. Cell lines with short life spans and high incidences of chromosome abnormalities resulted in poor blastocyst development following SCNT compared with long-lived, chromosomally normal cell lines (0.8% and 11.8% respectively; Mastromonaco et al. 2006) .
The efficiency of SCNT embryo production can be improved with the type of cell that is selected as nuclear donor. Various cell types have been utilised, including skin fibroblasts (Hill et al. 2000) , granulosa cells (Wakayama et al. 1998) , mammary gland cells (Wilmut et al. 1997 ) and muscle cells (Shiga et al. 1999 such as embryonic blastomeres, inner cell mass cells and embryonic stem cells, have also been used (Smith and Wilmut 1989; Wakayama et al. 1999) . Although donor age had an effect on the lifespan and cell cycle characteristics of fetal/newborn and adult cells, it did not influence SCNT blastocyst development (Hill et al. 2000; Kasinathan et al. 2001) and offspring have been produced from cells obtained from old reproductively senescent animals (Wells et al. 1998) . However, Wilmut et al. (2002) discussed the importance of donor stage of development (embryonic, fetal or adult), stating that the decreased percentage of live cloned offspring observed with cells from later stages of development reflects the degree of cellular differentiation and epigenetic constraints. Specifically, differences in reprogramming potential can be influenced by genetic background (inbred versus hybrid strains), genomic damage (mutations, loss of chromosome stability), genomic non-equivalence (elimination of a portion of the genome during differentiation) and epigenetic modifications (Oback and Wells 2002) . The data suggest, therefore, that adult skin fibroblasts may be one of the more inefficient donor cell types. Unfortunately, the reasons for attempting cloning in CANDES dictate that the most likely candidates will be adults and, for living individuals, the most practical and least invasive sample to retrieve will be skin. Further improvement of SCNT outcome can be attained with proper synchronisation of the donor cell cycle and recipient cytoplast, which permits the maintenance of normal ploidy and promotes epigenetic reprogramming in the reconstructed embryos (Oback and Wells 2002) . The optimal stage of the cell cycle depends on whether the recipient cytoplast is activated or not before transfer (Oback and Wells 2002) . As most SCNT protocols make use of non-activated oocytes, the quiescent G 0 /G 1 phase of the cycle is preferred. Different techniques have been employed to arrest cells in G 0 /G 1 , including serum starvation, confluence and incubation with chemical inhibitors. Although the number of blastocysts produced may not increase dramatically, a significantly greater percentage of viable calves at term has been observed (serum starvation: Wells et al. 2003; confluence: Gao et al. 2003b ; roscovitine treatment: Gibbons et al. 2002) .
These studies confirm the importance of the donor cell for SCNT success. Genetic and environmental factors have an impact on the viability and lifespan of cells grown in vitro, which directly affects the ability of SCNT embryos to be properly reprogrammed for pre-and post-implantation development. Genetically stable and actively replicating cell lines are required to minimise the introduction of aberrations into reconstructed embryos. Characteristics of a 'good' quality cell line are not fully understood; therefore, nuclear donors and their cell lines must be carefully screened. The implementation of standardised techniques for preparation and assessment of cell cultures is vital to the success of SCNT. Using proper selection criteria, cell lines with the potential for successful development can be identified for further study and banking.
The SCNT techniques
Although well developed SCNT protocols exist for various species, they are not readily transferable to other species. Basic aspects of the procedure, such as oocyte preparation (maturation, stripping and handling), cell-oocyte fusion, oocyte activation and donor cell preparation (culture establishment and synchronisation) must be optimised for each species. Donor cell type, passage number and changes in the SCNT technique (fusion, activation time, etc.) can affect gene expression in reconstructed embryos (Daniels et al. 2001; Wrenzycki et al. 2001) .
Availability of mature oocytes is an essential component of SCNT. This is one of the major obstacles in cloning the domestic dog. Poor success with the in vitro maturation (IVM) of canine oocytes has resulted in the use of oocytes matured in vivo adding to the difficulty of the technique as mature oocytes have to be flushed from the oviducts 72 h postovulation. Despite having standardised IVM protocols for the domestic cat, a recent study showed that the length of IVM has an effect on SCNT outcome (Skrzyszowska et al. 2002) . Although a greater percentage of meiotically mature oocytes are obtained after 42-45 h of IVM, these oocytes did not produce blastocysts following SCNT compared with oocytes matured for 24 and 35 h (8% and 8.5% blastocyst respectively), possibly owing to oocyte aging. As described previously, SCNT in non-domestic species usually involves the use of a related domestic recipient oocyte for which IVM protocols exist. Accordingly, oocyte source can affect developmental potential. Thongphakdee et al. (2006) observed higher blastocyst development with both marbled cat and domestic cat cells when fused with rabbit oocytes (11.5% and 7.7% respectively) compared with domestic cat oocytes (0% and 4.2% respectively). Similarly, the incidence of blastocyst development was higher after fusion of buffalo cells with domestic cattle oocytes than with buffalo oocytes (11.3% and 3.0% respectively; Lu et al. 2005) .
Transfer of donor nuclear material into the oocyte cytoplasm is affected by numerous factors, including the type of donor cell, age of the oocyte and method of cell introduction (electrofusion or injection). Parameters such as electric field strengths also vary, particularly with donor cell type. In the domestic cat, Karja et al. (2006) found that increased field strength resulted in increased fusion and cleavage rates, but had no effect on blastocyst development. In the horse, blastocyst development was improved by fusing the donor cell with zona-free instead of zonaintact oocytes (Lagutina et al. 2005) . In ferrets, fusion rates were increased by placing two cells into the perivitelline space instead of one (Li et al. 2005) . Direct injection of the donor cell into the cytoplasm may be used to overcome fusion problems for especially difficult species such as the horse (Hinrichs et al. 2006) .
It is crucial that the newly reconstructed embryo be activated properly for development to proceed. Electrical or chemical (alcohol, calcium ionophore, 6-dimethylaminopurine (6-DMAP), cycloheximide) methods are used to activate the oocyte in an attempt to simulate the increase in intracellular calcium that is induced by the fertilising sperm. However, in certain species, standard techniques have not been sufficient and alternatives have been devised. In the horse, Choi et al. (2004) showed that the injection of sperm extract and culture in 6-DMAP produced higher cleavage rates. In a subsequent study, the injection of roscovitine was included in the activation process, but without a significant effect on the outcome (Hinrichs et al. 2006) .
Embryo culture has been well established in domestic species and media have been optimised to reduce in vitro stressors, such as oxygen tension, and exclude the use of undefined components, such as serum. As a result, initial efforts at culture of embryos from other species usually involve the use of established culture systems. However, the species-specific nature of embryo development requires the selection or development of a medium that supports the needs of the particular species. Thus, SCNT success in non-domestic species can be increased possibly with the development of optimised culture systems. In the bongo, reconstructed embryos were cultured in both hamster embryo culture medium-6 and modified synthetic oviductal fluid and significant differences in blastocyst development were observed (24.2% and 11.2% respectively; Lee et al. 2004) . Similarly, the use of co-culture on a murine cell monolayer improved blastocyst development of Tibetan antelope SCNT embryos in Charles Rosenkrans-1 with amino acid medium (4% compared with 0% without co-culture; Zhao et al. 2007) . Interestingly, studies in mice have shown that SCNT embryos exhibit improved development in somatic cell culture conditions as compared with standard embryo culture conditions (Heindryckx et al. 2001; Gao et al. 2003a) . These studies suggest that the preference of SCNT embryos for somatic-cell-specific culture media is associated with the continued expression of somatic genes (Gao et al. 2003a) . Thus, if the initial physiological state of the donor cell affects the response of SCNT embryos to the culture environment Gao et al. 2003a) , it is important to develop conditions for the specific requirements of the preimplantation SCNT embryo. Our studies support these findings, as we observed that although protein supplementation of the embryo culture medium (serum versus bovine serum albumin) had no major effects on IVF embryos, SCNT embryos were more affected by the lack of serum in the culture medium (Mastromonaco et al. 2004b) . In addition to a lower number of matured oocytes following IVM, absence of serum resulted in impaired development of reconstructed embryos (decreased blastocyst and hatching rates), thereby suggesting that different requirements are necessary to maintain the physiologic state of SCNT embryos (Mastromonaco et al. 2004b) .
It is well recognised that every component of the SCNT procedure has the potential to disrupt the ultimate outcome (Campbell 1999; Smith et al. 2000a) . Thus, parameters pertaining to the cell donor and donor cells, techniques involved in SCNT, culture environment and reconstructed embryos must be investigated for each species to establish a SCNT protocol with the greatest potential for embryo development. With proper cytogenetic assessment of donors, initiation and assessment of donor cell lines and selection of a suitable embryo culture environment, the production of developmentally competent SCNT embryos can be achieved. Furthermore, identification of speciesspecific markers for embryo quality and viability are important for understanding preimplantation development and assisting in the development of improved in vitro systems.
The reconstructed embryo
Embryo development beyond the early cleavage stages is dependent on the activation of the embryonic genome, which occurs at a species-specific stage (Memili and First 2000) . A smooth transition from maternal to embryonic control requires compatibility between the nucleus directing the cell cycle and the cytoplasmic components, so that proper nuclear remodelling and reprogramming can occur. Failure to reprogram properly leads to immediate embryonic death, whereas partial reprogramming results in embryo survival with subsequent physiological abnormalities or lethalities at later developmental stages (Rideout et al. 2001) . When complete reprogramming occurs, the characteristics of SCNT embryos should be similar to those of in-vitro-and in-vivo-produced embryos, but numerous alterations occur in SCNT embryos. Poor developmental outcome in SCNT embryos has been attributed to alterations in gene expression (Daniels et al. 2001; Wrenzycki et al. 2001; Jang et al. 2005) , changes in cell number and cell allocation (Koo et al. 2002 (Koo et al. , 2004 , increased incidence of apoptosis (Fahrudin et al. 2002; Gjorret et al. 2003; Park et al. 2004 ) and an increase in chromosomally abnormal cells (Booth et al. 2003; Slimane Bureau et al. 2003; King et al. 2006) .
Recently, more attention has been given to the interaction between the cytoplasm and nucleus and, in the case of SCNT, to the effects that may be exerted by the oocyte cytoplasm on the foreign nucleus and vice versa. This communication is of critical importance in interspecies/intergeneric SCNT, where the nucleus is unrelated or evolutionarily distinct from the cytoplasm. Owing to size discrepancies between a somatic cell and an oocyte, most of the mRNAs, proteins, organelles and other cytoplasmic components are contributed by the unrelated oocyte. Studies of SCNT embryos are beginning to delineate the significance of proper cytoplasmic organisation and intracellular communication on embryo development. For instance, it has been shown that centrosomes, essential components of the mitotic spindle, are introduced by the donor cell into the reconstructed embryo (Shin et al. 2002b) . Defects in centrosome organisation and function create errors during cell division that result in chromosome instability and aneuploidies (Sankaran and Parvin 2006) . Abnormal centrosome replication, distribution and function have been associated with poor developmental potential of SCNT embryos (Dai et al. 2006) . In contrast, mitochondria are inherited primarily from the recipient ooplasm, with only a small number contributed by the donor cell. The species-specific nature of this organelle's biogenesis and function (Kenyon and Moraes 1997; Barrientos et al. 1998 ) makes it particularly significant for interspecies SCNT. Any alterations in mitochondrial structure, location and mtDNA copy numbers correspond to changes in respiratory function and, subsequently, in ATP levels. Decreased ATP levels during the energy-demanding stages of embryo development have detrimental effects on the embryo's ability to carry out basic cellular functions and undergo further development. Furthermore, mitochondria play an active role in regulation of the apoptotic cascade, which is crucial for embryogenesis, tissue homeostasis and cellular response to injury (Raff 1992) .
Both intraspecies (donor nucleus and recipient cytoplasm from different individuals of a single species) and interspecies (donor nucleus and recipient cytoplasm from two different, closely related or unrelated species) SCNT embryos are at risk of mitochondria-related defects. Studies in domestic cattle have shown that mitochondrial lineages affect blastocyst development, with certain mtDNA haplotypes producing greater numbers of blastocysts and a related increase in ATP levels (Tamassia et al. 2003 (Tamassia et al. , 2004 . Similarly, the proportion of transferable SCNT embryos produced was affected by the mitochondrial lineage of recipient oocytes (Bruggerhoff et al. 2002) . Mitochondrial heteroplasmy, the presence of more than one lineage of mitochondria, is postulated to create conflict between the mitochondrial and nuclear control elements, leading to a disruption of mitochondrial biogenesis (Cummins 2001) . Studies have shown that SCNT embryos are heteroplasmic, consisting of mtDNA from both the donor cell and recipient cytoplasm (Steinborn et al. 2002; Takeda et al. 2002; . It has been suggested that this may contribute to the poor developmental outcome of SCNT embryos and possibly the phenotypic variation observed in cloned offspring . Examination of heteroplasmic SCNT embryos produced from Bos taurus oocytes and donor cells of different mtDNA haplotypes showed that the type of recipient cytoplasm affected embryonic/fetal developmental potential, fetal phenotype (weight and dimensions) and metabolism . However, other studies report that no detrimental effect of heteroplasmy manifests itself in SCNT embryos or offspring. Evidence of the presence of donor mtDNA during all stages of development and in offspring born from SCNT embryos has been recorded (Hiendleder et al. 1999; Do et al. 2002; Han et al. 2004) .
A shift to mitochondrial homoplasmy in SCNT embryos and offspring has also been documented. Studies using genetically similar species (Meirelles et al. 2001) or different mtDNA haplotypes within the same species (Steinborn et al. 1998) indicate that, under certain circumstances, there is no replicative advantage to the donor mtDNA. Thus, equal segregation of the mitochondria to the daughter blastomeres results in a decrease in the percentage of donor mtDNA with increasing cell number (Steinborn et al. 1998) . In cases of SCNT between Bos indicus and Bos taurus, reduction or complete elimination of the donor-cell mtDNA occurred by the end of the gestation period (Smith et al. 2000b; Meirelles et al. 2001) . Since the blastocyst development and pregnancy rates were similar to Bos taurus controls, this suggests that there was no effect of mtDNA type on nuclear-mitochondrial communication. These authors proposed that the highly conserved mtDNA sequences allow the . Despite the similarities in apoptotic incidence in both treatment groups, a significant decrease in cell number and poor blastocyst formation was observed in the gaur-cattle SCNT embryos.
Bos indicus nuclear-encoded factors to interact with the Bos taurus mtDNA (Meirelles et al. 2001) . It would appear that in closely related species (or subspecies such as Bos taurus and Bos indicus), mitochondrial homoplasmy with an unrelated nuclear background may not interfere with respiratory function and embryo development; however, a recent study of Bos gaurusBos taurus interspecies SCNT embryos indicates otherwise (Mastromonaco et al. 2007) . Gaur-cattle interspecies SCNT embryos were found to be primarily homoplasmic for domestic cattle mtDNA; therefore, these embryos consisted of a gaur nuclear genome directing the cattle mitochondrial genome and cytoplasmic components. The embryos were developmentally compromised as evidenced by poor blastocyst quality (Fig. 2) and quantity as compared with domestic cattle SCNT controls (18.1% versus 42.3% blastocyst development respectively). Signs of disrupted cellular processes associated with mitochondrial function, including delayed development, decreased cell number and a decrease in the ratio of BCL2:BAX (pro-survival: pro-apoptotic) expression without a corresponding increase in apoptotic incidence were observed (Mastromonaco et al. 2007 ). The potential role of nuclear-cytoplasmic interactions on the poor developmental outcome in these embryos is substantiated by the fact that SCNT embryos produced using donor cells from a gaur × cattle fetus (i.e. an embryo consisting of 50% gaur: 50% domestic cattle nuclear genome within a cattle cytoplasm) exhibited improved development (32.5% versus 18.1% blastocyst rate), implying that some compatibility may occur when cattle mitochondria are complemented with some cattle nuclear genes (Mastromonaco et al. 2007) . Similarly, the successful production of mule clones following interspecies SCNT using mule cells (50% donkey:50% horse nuclear genome) and horse oocytes (Woods et al. 2003) may have occurred as a result of the compatibility that existed between the horse cytoplasm and the horse portion of the nuclear genome. A shift to mitochondrial homoplasmy also arises when two divergent species are involved (Chen et al. 2002; Yang et al. 2003) . However, it is the donor mtDNA that persists and is selectively replicated. Giant panda-rabbit (Ailuropoda melanoleucaOryctolagus cunniculus) and macaque-rabbit (Macaca mulattaOryctolagus cunniculus) SCNT embryos consisted of only donor mtDNA after implantation. Yang et al. (2004) suggested that among genetically similar species, recipient mtDNA dominates, because nuclear-encoded factors are able to interact with recipient mitochondria. In genetically diverse species, decreased or failed communication between the distinct nuclear and recipient mitochondrial control elements may necessitate replication of the donor mtDNA. If the donor mtDNA is preferentially replicated, then nuclear-mitochondrial compatibility factors are no longer an issue. Nonetheless, it is well documented that interspecies SCNT embryos between highly distinct species exhibit poor developmental potential, usually arresting before activation of the embryonic genome (e.g. rat-domestic cattle: 2-cell stage, Dominko et al. 1999; llama-domestic cattle: 8-16-cell stage, Sansinena et al. 2003 ; tiger-domestic cattle: 1.8% blastocyst, Hwang et al. 2001 ; black bear-domestic cattle: 4% blastocyst, Ty et al. 2003) . According to the results from giant pandaand macaque-rabbit SCNT embryos, if nuclear-mitochondrial communication is established with the replication of the donor mtDNA, then the decreased development exhibited by interspecific embryos must be caused by other cytoplasmic factors.
The extent to which nuclear-cytoplasmic interactions in either heteroplasmic or homoplasmic embryos with a foreign nuclear background affects nuclear reprogramming and subsequent embryonic gene expression is not clearly delineated.
Despite the dramatic effects of nuclear-mitochondrial interaction, or lack thereof, in hybrids, conflicting evidence in SCNT embryos and fetuses suggests that factors other than mitochondrial make-up may be involved in establishing normal nuclear-cytoplasmic communication. A better understanding of basic intracellular dynamics is required to increase SCNT success, with the end result being increased production of healthy cloned individuals.
Feasbility of SCNT for animal production
Attempts to produce SCNT embryos have shown that preimplantation embryo development can be achieved in the majority of species investigated to date. However, embryo quality and potential for post-implantation development are primary factors that determine whether embryo transfer and subsequent production of cloned offspring is a realistic goal. As discussed in preceding sections, transfer of SCNT embryos results in low pregnancy rates, with <5% of the embryos developing to live offspring. A high frequency of early trimester losses (Hill et al. 2000) as well as late gestation and post-natal losses are observed with SCNT pregnancies as compared with in-vitro-fertilised and in-vivo-control pregnancies (Heyman et al. 2002; Tsunoda and Kato 2002) . In most SCNT pregnancies, the high rate of mortality is associated with placental malformation (Hill et al. 2000; Loi et al. 2006) . Placental insufficiency resulting from abnormal cotyledon formation, decreased numbers of cotyledons, placental degeneration and reduced placental vascularisation is considered to be the cause of diseases typically documented in SCNT fetuses and neonates, including respiratory distress, malnutrition and cardiopulmonary disease (Hill et al. 1999 (Hill et al. , 2000 Loi et al. 2006) .
In recent years, aberrant methylation of the genome has been linked to SCNT pregnancy failure. Increased levels of DNA methylation resembling patterns displayed by somatic cells are postulated to play a role in post-implantation failure characterised by placental and fetal abnormalities (Bourc'his et al. 2001; Dean et al. 2001) . Dindot et al. (2004) showed that SCNT causes disruption of genomic imprinting and hypermethylation in the chorion but not the fetus. This was correlated with the occurrence of placental abnormalities (decreased number of placentomes and reduction in chorio-allantoic fusion), whereas no abnormalities were observed in the fetuses themselves. The authors concluded that a difference exists in the disturbance of gene expression between the inner cell mass and trophectoderm cell lineages of the blastocyst.
The low success rates for SCNT technologies in all species demonstrate the difficulty in reproducing an individual by cloning. The multiple attempts necessary to obtain a viable and healthy cloned individual are costly. According to recent rates in the USA, the price for one clone ranges from US$15 000 for cattle to upwards of US$32 000 for cats. Cloned horses are at a premium, with a cost of US$150 000 each. These rates are prohibitively expensive for most individuals (companion animal owners) and animal managers (wildlife organisations, zoological institutions) and, in many cases, difficult to justify for the re-creation of one individual. Furthermore, the high incidences of pre-and post-natal problems with clones and the inability to guarantee how they will perform (reproductively or otherwise) make it difficult to promote this technology as a viable option for animal production.
Future of SCNT in CANDES
The potential exists for SCNT technology to provide an alternative strategy for the creation of economically, genetically and emotionally valuable individuals. The advantages of this method of assisted reproduction are considerable: the propagation of individuals unable to produce viable gametes, the distribution of genetic material without relying on the intricacies of gamete/embryo handling and, most importantly, the preservation of an individual's entire genome. Establishment and effective management of cell banks can be used in conjunction with assisted reproductive technologies in a multi-step program to salvage both the nuclear and mitochondrial genomes of valuable individuals. Appropriate use of SCNT can offer numerous possibilities to assist and improve breeding management strategies but, currently, the technology is plagued with a host of problems. There are too many unknown factors and sub-optimal conditions to efficiently produce live healthy animals. Thus, a level of uncertainty surrounds the future of SCNT for the production of animals that are not for commercial, medical or research purposes. Having come thus far with our ability to turn differentiated somatic cells into embryonic cells, now is the time for a decision to be made regarding whether we move ahead to overcome the obstacles in an effort to create an applicable technique or we abandon this avenue altogether. Wildlife/zoological organisations, animal managers and breeders must work together with researchers and academic institutions to gain further insight into the basic aspects of cell function, embryo development and fetal-maternal interaction. It is only with a better understanding of the physiology of the reconstructed embryo that SCNT success can be improved and the technology be considered a valuable tool for assisted reproduction in CANDES.
